Internet-based indicated prevention of anxiety and depression disorder onset three-arm randomized clinical trial - Scorecard - MDSpire

Internet-based indicated prevention of anxiety and depression disorder onset three-arm randomized clinical trial

  • By

  • Anna-Carlotta Zarski

  • Kiona K. Weisel

  • Thomas Berger

  • Tobias Krieger

  • Michael P. Schaub

  • Matthias Berking

  • Dennis Görlich

  • Corinna Jacobi

  • Rosa Baños

  • Cristina Botella

  • Rocio Herrero

  • David D. Ebert

  • October 1, 2025

  • 0 min

Share

Clinical Scorecard: Efficacy of Internet-Delivered Targeted Prevention for Onset of Anxiety and Depression: A Three-Arm Randomized Controlled Trial

At a Glance

CategoryDetail
ConditionAnxiety and depressive disorders
Key MechanismsInternet-based, transdiagnostic, self-tailored cognitive behavioral therapy (CBT) sessions targeting subthreshold anxiety and depressive symptoms
Target PopulationAdults with subthreshold anxiety (GAD-7 ≥ 5) and/or depressive symptoms (CES-D ≥ 16) without clinical diagnosis in past six months
Care SettingInternet-delivered intervention with either individual or automated guidance

Key Highlights

  • Both individually guided and automatically guided internet-based interventions significantly reduced the 12-month onset of anxiety and depressive disorders compared to waitlist control.
  • Cumulative incidence of disorder onset was 23.1% (individually guided), 20.7% (automated guided), and 36.0% (waitlist control).
  • Number needed to treat (NNT) was 7.76 for individually guided and 5.79 for automated guided interventions, indicating effective prevention.

Guideline-Based Recommendations

Diagnosis

  • Use standardized diagnostic interviews (e.g., MINI 6.0) to confirm absence of clinical anxiety or depressive disorders at baseline.
  • Assess subthreshold symptoms using validated scales such as GAD-7 for anxiety and CES-D for depression.

Management

  • Implement transdiagnostic, self-tailored CBT-based internet interventions comprising 8 sessions for indicated prevention in adults with subthreshold symptoms.
  • Offer interventions with either individualized human guidance or automated guidance to enhance adherence and efficacy.

Monitoring & Follow-up

  • Conduct follow-up diagnostic interviews at 6 and 12 months to assess onset of anxiety or depressive disorders.
  • Monitor session completion rates to evaluate adherence and engagement with the digital intervention.

Risks

  • No specific risks reported; however, adherence may influence outcomes and should be supported.
  • Ensure participants do not have recent clinical diagnoses to target indicated prevention appropriately.

Patient & Prescribing Data

Adults with subthreshold anxiety and/or depressive symptoms without recent clinical diagnosis

Both individually guided and automated internet-based CBT interventions effectively reduce incidence of anxiety and depressive disorders over 12 months, with automated guidance showing slightly lower cumulative incidence and NNT.

Clinical Best Practices

  • Screen patients for subthreshold anxiety and depression using validated symptom scales before intervention.
  • Use transdiagnostic and self-tailored CBT modules to address comorbid anxiety and depressive symptoms simultaneously.
  • Provide guidance (individual or automated) to improve adherence and intervention effectiveness.
  • Follow patients longitudinally with diagnostic interviews to confirm prevention of disorder onset.

References

Original Source(s)

Related Content